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Background/aim: Myocarditis in the acute phase usually presents with sinus tachycardia but many other arrhythmias might be seen as
well. In this study we aimed to investigate repolarization abnormalities in baseline ECG of patients with myocarditis for the first time.
Materials and methods: Thirty patients diagnosed with myocarditis and 25 healthy age-matched controls were included. Two different
cardiologists measured corrected QT (QTc), QT dispersion (QTd), QT peak (QTp), T wave peak to T wave end (TpTe), TpTe/QT ratio,
and TpTe/QTc ratio in 12-lead ECG.
Results: When compared with the control group, QTp (P: 0.021), QT (P: 0.003), TpTe (P < 0.001), TpTe/QTc ratio (P < 0.001), and TpTe/
QT ratio (P: 0.005) were significantly higher in patients with myocarditis. A comparison of receiver operating characteristic (ROC)
curves was conducted using the Hanley and McNeil method. The area under the curve (AUC) of the electrocardiographic characteristics
QT (AUC: 0.736; 95% CI [0.600–0.846]), QTP (AUC: 0.680; 95% CI [0.540–0.799]), and TpTe (AUC: 0.771; 95% CI [0.638–873]) and
TpTe/QTc (AUC: 0.774; 95% CI [0.641–0.876]) and TpTe/QT (AUC: 0.726; 95% CI [0.589–0.838]) in myocarditis were not significantly
different from each other but all of them were different from 0.5.
Conclusion: Baseline ECGs of patients with myocarditis were associated with repolarization abnormalities. These novel findings may
be one of the reasons underlying arrhythmic events in patients with myocarditis.
Key words: Myocarditis, repolarization abnormalities, TpTe

1. Introduction
Myocarditis is an inflammatory disease of the heart
muscle produced by infectious or noninfectious causes
(1). Viral infections are the most common presumed
causes but incidence of myocarditis is highly variable
in the published data. Diversity in etiology, clinical
manifestations, and diagnostic criteria challenge
physicians for determination of an algorithm. The
clinical presentation of myocarditis can range from
subclinical disease to life-threatening heart failure,
cardiogenic shock, arrhythmia, or sudden cardiac death
(2–4).
While sinus tachycardia is the most common
arrhythmia, many different forms including lifethreatening arrhythmias such as ventricular tachycardia
can be seen during the myocarditis course (5). Even
though the exact mechanisms leading to sudden cardiac
death during myocarditis remain to elucidated, various
* Correspondence: dr_muratgunes@hotmail.com

molecular and immunopathogenetic reasons have
been proposed. Arrhythmogenic substrates secondary
to viral-induced myocardial injury may both invoke
formation of reentry circuits and trigger ventricular
arrhythmia by acting as a proarrhythmic substrate or
causing ion channel dysfunction (5).
Recent studies showed that electrocardiographic
indicators of myocardial repolarization, which are QT
interval corrected QT (QTc) interval and QT dispersion
(QTd), are associated with several conditions (6,7).
Novel indices such as TpTe interval and TpTe/QT
have emerged as markers associated with ventricular
arrhythmias (6,7).
The present study aimed to investigate myocardial
repolarization in patients with myocarditis and lifethreatening ventricular arrhythmias by using the
parameters QT, QTc, QTd, QT peak (QTp), TpTe/QT,
and TpTe/QTc.
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2. Materials and methods
2.1. Study population
Our patient population consisted of 30 patients diagnosed
with myocarditis between 2013 and 2015 in a retrospective
fashion. Twenty-five healthy subjects with similar age and
demographic characteristics who were admitted to the
outpatient clinic for atypical symptoms were assigned
as the control group. All of the patients had a recent
history of upper or lower respiratory tract infection 2–3
weeks before the index event and no etiologic agents were
identified except for in 2 patients in which influenza virus
antigen was detected in nasal secretions. Medical history
and physical examination, ECG, echocardiography,
coronary angiography and cardiac biomarkers were used
for diagnosis of myocarditis. Cardiac magnetic resonance
(CMR) scanning was performed only in 2 patients.
Patients were excluded if they had coronary artery
disease, moderate/severe valve disease, chronic lung
diseases, severe hepatic and renal dysfunction, thyroid
dysfunction, anemia, electrolyte imbalance, bundle branch
block, atrioventricular conduction abnormalities on ECG
and ECG without clearly analyzable QT-segment, or
were receiving medications with effects on heart rhythm
and conduction system (antiarrhythmic drugs, digitalis,
β-blocker, calcium-channel blocker, antipsychotics, and
antihistaminics).
2.2. Diagnosis of myocarditis
The diagnosis of myocarditis was made according to
the criteria mentioned in the position statement of the
European Society of Cardiology Working Group on
Myocardial and Pericardial Diseases, which were as listed
below (1).
2.3. Clinical presentations
• Acute chest pain, pericarditic, or pseudoischemic
• New-onset (days up to 3 months) or worsening of:
dyspnea at rest or exercise, and/or fatigue, with or without
left and/or right heart failure signs
• Subacute/chronic (>3 months) or worsening of:
dyspnea at rest or exercise, and/or fatigue, with or without
left and/or right heart failure signs.
• Palpitation, and/or unexplained arrhythmia
symptoms and/or syncope, and/or aborted sudden cardiac
death
• Unexplained cardiogenic shock.
2.4. Diagnostic criteria
I. ECG/Holter/stress test features: Newly abnormal 12
lead ECG and/or Holter and/or stress testing, any of the
following: I to III degree atrioventricular block, or bundle
branch block, ST/T wave change (ST elevation or nonST elevation, T wave inversion), sinus arrest, ventricular
tachycardia or fibrillation and asystole, atrial fibrillation,
reduced R wave height, intraventricular conduction delay
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(widened QRS complex), abnormal Q waves, low voltage,
frequent premature beats, supraventricular tachycardia,
II. Myocardiocytolysis markers Elevated TnT/TnI,
III. Functional and structural abnormalities on cardiac
imaging (echo/angio/CMR) New, otherwise unexplained
LV and/or RV structure and function abnormality
(including incidental finding in apparently asymptomatic
subjects): regional wall motion or global systolic or
diastolic function abnormality, with or without ventricular
dilatation, with or without increased wall thickness, with or
without pericardial effusion, with or without endocavitary
thrombi,
IV. Tissue characterization by CMR edema and/or
LGE of classical myocarditic pattern. Clinically suspected
myocarditis if ≥1 clinical presentation and ≥1 diagnostic
criteria from different categories, in the absence of: (1)
angiographically detectable coronary artery disease
(coronary stenosis ≥50%); (2) known preexisting
cardiovascular disease or extracardiac causes that could
explain the syndrome (e.g., valve disease, congenital heart
disease, hyperthyroidism). If the patient is asymptomatic
≥2 diagnostic criteria should be met.
2.5. Echocardiography
All echocardiographic measures were performed according
to the American Society of Echocardiography guidelines
(8). Left ventricle (LV) dimensions were measured in the
parasternal long axis view. From the parasternal axis, the
aorta, left atrium, LV systolic and diastolic diameters,
interventricular septum, and posterior wall thicknesses
were measured as the patients were positioned in the left
lateral decubitus position. Left ventricular ejection fraction
(EF) was calculated by the Teichholz method.
2.6. Electrocardiography
Baseline 12-lead ECGs of patients with myocarditis
were recorded with a paper speed of 25 mm/s and
standardization of 1.0 mV/cm on the day of admission.
R-R interval, QT interval, QTp, and TpTe intervals were
manually measured by two experienced cardiologists blind
to the clinical characteristics of the patients. QT interval
was defined as the interval between from the beginning of
the QRS complex to the end of T-wave. The QT intervals
were corrected according to the formula of Bazzett,
where QTc = QT/√RR. QT dispersion was calculated as
the difference between longest and shortest QT intervals.
TpTe interval was defined as the interval from the peak of
the T wave to the end of the T wave. TpTe/QTc and TpTe/
QT ratios were calculated from obtained measurements.
Measurements were recorded from precordial leads.
2.7. Statistical analysis
Continuous variables are expressed as median [range].
Categorical data are shown in frequencies and percentages.
The Mann–Whitney U test was used to compare differences
between the groups due to the small sample size. Fisher’s
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exact test and continuity correction (Yate’s correction)
test were used to test the categorical variables. Receiver
operating characteristics (ROC) curves were used to
evaluate the effectiveness of each ECG parameter as a
screening method for myocarditis. Comparison of ROC
curves was performed to test the statistical significance
of the difference among the area under the curve (AUC)
dependent ROC curves (derived from the same cases)
with the method of Hanley and McNeil. Statistical tests
were 2-tailed, and results were regarded as significant at or
below the 5% probability level. The intraclass correlation
coefficient (ICC) and its 95% confidence interval (CI)
were used to assess interobserver reliability between the
first and the second cardiologist. Statistical Package for the

Social Sciences (SPSS version 22.0, SPSS Inc., Chicago, IL,
USA) and MedCalc software were used.
3. Results
The comparison of demographic characteristics is shown
in the Table. Age, hypertension, diabetes mellitus, and
smoking were matched between the patient and control
groups. EF (61 [67–30] vs. 66 [74–54], P < 0.001), end
systolic diameter (ESD) (3.1 [4.6–2.2] vs. 2.9 [3.7–2.3], P:
0.031), and E/a ratio (1.09 [1.8–0.5] vs. 0.7 [1.5–0.44], P:
0.032) were significantly different between the two groups
as echocardiographic parameters. When compared with
the control group, QTp (0.29 [0.34–0.25] vs. 0.27 [0.31–
0.25], P: 0.021), QT interval (0.36 [0.43–0.32] vs. 0.34

Table. Basic clinical and laboratory characteristics of the patient and control groups.

Age, years

Patient (n: 30)

Control (n: 25)

P

29 [52–20]

29 [38–22]

0.886

HT (%)

7 (30.4)

3 (14.3)

0.287

DM (%)

5 (20)

2 (10.5)

0.680

Smoking (%)

7 (23.3)

6 (24)

1

ECG characteristics
QTp

0.29 [0.34–0.25]

0.27 [0.31–0.25]

0.021

QT interval, s

0.36 [0.43–0.32]

0.34 [0.40–0.30]

0.003

QTd interval, s

0.03 [0.08–0.01]

0.02 [0.05–0.01]

0.219

QTc interval, s

0.40 [0.46–0.36]

0.39 [0.43–0.33]

0.379

TpTe interval, s

0.10 [0.15–0.08]

0.09 [0.12–0.07]

<0.001

TpTe/QTc ratio

0.26 [0.33–0.20]

0.22 [0.29–0.17]

0.001

TpTe/QT ratio

0.28 [0.36–0.22]

0.25 [0.33–0.19]

0.005

3.4 [4.4–3]

3.4 [3.8–3]

0.858

EF (%)

61 [67–30]

66 [74–54]

<0.001

ESD (mm)

3.1 [4.6–2.2]

2.9 [3.7–2.3]

0.031

EDD (mm)

4.7 [6–2.8]

4.6 [6–4]

0.727

E wave, cm/s

0.68 [1.1–0.5]

0.60 [1.3–0.4]

0.135

A wave, cm/s

0.74 [1.3–0.4]

0.8 [1.2–0.4]

0.215

E/A ratio

1.09 [1.8–0.5]

0.7 [1.5–0.44]

0.032

Echocardiography
LA size (cm)

E’, m/s

0.10 [0.16–0.05]

0.08 [0.15–0.03]

0.073

E/E’ ratio

7.5 [12–5]

8 [13–6]

0.308

Septum, cm

1.1 [1.2–0.8]

1.1 [1.3–0.8]

0.760

Posterior wall, cm

1.06 [1.2–0.6]

1.05 [1.3–0.8]

0.352

Basal troponin, ng/dL

0.30 [4–0]

A wave: Late ventricular filling velocity, DM: Diabetes mellitus, E wave: Early ventricular filling velocity,
EF: Ejection fraction, HT: Hypertension, LA: Left atrium, QTc: corrected QT, QTd: QT dispersion, QTp:
QT peak, TpTe: T wave peak to T wave end
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[0.40–0.30], P: 0.003), TpTe (0.10 [0.15–0.08] vs. 0.09 [0.12–
0.07], P < 0.001), TpTe/QTc ratio (0.26 [0.33–0.20] vs. 0.22
[0.29–0.17], P < 0.001), and TpTe/QT ratio (0.28 [0.36–0.22]
vs. 0.25 [0.33–0.19], P: 0.005) were significantly higher in
patients with myocarditis. QT dispersion interval and QTc
interval were not significantly different between the groups.
The area under the ROC curve (AUC) for the
electrocardiographic characteristics QT (AUC: 0.736, 95%
CI [0.600–0.846]), QTP (AUC: 0.680, 95% CI [0.540–
0.799]), and TpTe (AUC: 0.771, 95% CI [0.638–0.873]) and
TpTe/QTc (AUC: 0.774, 95% CI [0.641–0.876]) and TpTe/
QT (AUC: 0.726, 95% CI [0.589–0.838]) in myocarditis were
not significantly different from each other but all of them
were different from 0.5 by the Hanley and McNeil method
(Figure).
3.1. Reproducibility
QT interval, QTd, QTp, and TpTe interval were calculated
by the first experienced cardiologist and then a second
experienced cardiologist, who were blinded to the first
measurements. The interobserver reproducibility of
selected ECG parameters was satisfactory. For interobserver
reliability ICCs were significant for QT interval (0.953; 95%
CI [0.921–0.973]), QTp (0.956; 95% CI [0.925–0.974]), QTd
(0.920; 95% CI [0.867–0.953]), and TpTe interval (0.881;
95% CI [0.804–0.929]).
4. Discussion
In the present study, we compared myocardial repolarization
parameters in baseline ECGs of patients with myocarditis

with those of the control group and found that QTp, QTc,
TpTe interval, TpTe/QTc ratio, and TpTe/QT ratio were
significantly higher in the patient group. When AUC values
of these parameters were compared, none of them was
superior for prediction of myocarditis.
Myocarditis can occur due to both infectious and
noninfectious causes; however, the most common etiologic
causes are viral agents. The most important causes of
myocarditis in North America and Europe are enterovirus
(especially Coxsackie virus), Parvo virus B19, and Human
Herpes Virus 6 (HHV-6). Systemic diseases, cardiotoxic
agents, agents that can induce hypersensitivity reactions,
and many different types of bacteria, fungi, and parasites
can cause myocarditis (9–11). Myocarditis may have a
great variety of manifestations ranging from subclinical
setting (fever, palpitation, exertional dyspnea, myalgia)
to a fulminant course (hemodynamic collapse, syncope)
(3,4). Because of variety in clinical presentations, it is
hard to detect the real incidence of myocarditis precisely.
Serious complications may occur in both the early and late
phase of disease course; atrial and ventricular arrhythmias,
total atrioventricular heart block with hemodynamic
compromise, or sudden cardiac death may occur in the
early course and heart failure in the late course (4,11,12).
In the study by Felker et al., which recruited 1230 patients
with unexplained heart failure, myocardial disease was
considered to be the underlying reason in 9% of the patients
(11). Furthermore, another study in which endomyocardial
biopsy was performed in 2200 patients with unexplained

Figure. Comparison of ROC curves by the Hanley and McNeil method for myocarditis.
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cardiomyopathy revealed that myocarditis was the
underlying cause in 10% of the patients (13). In the context
of sudden cardiac death, Drory et al. studied subjects
aged <40 years suffering sudden unexpected death and
showed that myocarditis was the underlying cause of
sudden unexpected death in 22% of subjects aged less
than 30 years while it was 11% in older patients (12). The
medical history of our patient population suggests viral
causes since no specific etiologic agent could be identified.
Although impaired left ventricular systolic function was
common in our patients, no life-threatening arrhythmia
or sudden cardiac death was seen.
Previous studies demonstrated that fibrosis and
scarring of myocardium, secondary hypertrophy, and
atrophy can induce ventricular arrhythmias via ectopic
pacemakers, late potentials, and reentry as a result of
nonhomogeneous conduction. Meanwhile, ongoing
inflammatory processes in the cardiac myocytes and
interstitium may directly trigger arrhythmias through
oscillations in membrane potential. Therefore, secondary
changes due to ongoing inflammation in myocardial tissue
may induce repolarization abnormalities associated with
sudden cardiac death (14,15).
Ventricular
myocardium
contains
3
electrophysiologically distinct types of cells: epicardial,
endocardial, and m-cell (myocardial) cells. M-cells
have larger late-sodium and sodium/calcium exchange
channels and weaker slowly activating delayed rectifier
current and so they are more susceptible to repolarizationprolonging insult and serious ventricular arrhythmias
(16). Myocardial repolarization is assessed by different
indices including QT, QTc, QT dispersion, TpTe interval,
TpTe/Qt ratio, and TpTe/QTc, which are accepted as
indicators of QT dispersion, corrected QT dispersion, and
transmural repolarization dispersion in various studies
(7,17). Prolonged QTc was shown to be the most common
ECG finding in a study that examined 20 patients with
myocarditis and suffering serious complications (lifethreatening arrhythmias) (18). Similarly, when Amoozgar
et al. compared patients with Kawasaki disease and a control
group, they took QT interval as an index of transmural
dispersion of repolarization and found that both QT and
QTc interval were prolonged in the patient group (19).
Prolonged QT interval in hypertrophic cardiomyopathy

was associated with nonsustained ventricular tachycardia
in another study (20). Another well-investigated index of
transmural dispersion of repolarization is TpTe, which
was shown to be helpful for predicting the risk for lifethreatening ventricular arrhythmias (21). Furthermore,
previous studies reported that prolonged TpTe was
associated with ventricular arrhythmia and sudden cardiac
death in patients with hypertrophic cardiomyopathy
(22), end-stage renal failure (23), inducible ventricular
tachycardia (24), recent MI (25), long-QT syndrome (26),
operated tetralogy of Fallot (27), and Brugada syndrome
(28). TpTe/QT and TpTe/QTC, relatively novel markers for
repolarization abnormalities, are not affected by heart rate
and body mass in contrast to TpTe (29). Several conditions
assumed to be associated with myocardial inflammation
such as ankylosing spondylitis (30), rheumatoid arthritis
(31), chronic hepatitis B (7), nondipper hypertension
(32), and anabolic/androgenic steroid use (33) were also
associated with prolonged TpTe and TpTe/QT.
In this study, we investigated ECG parameters
associated with dispersion of repolarization in patients
with myocarditis for the first time in the literature.
Repolarization abnormalities are expected to occur due to
pathologic processes of myocardial inflammation during
the course of myocarditis. A simple way for recognition
of repolarization abnormalities and estimation of the risk
for life-threatening arrhythmias in myocarditis, which can
have various clinical manifestations, may be helpful for
optimal management of patients with myocarditis.
5. Conclusion
Baseline ECGs of patients with myocarditis were
associated with repolarization abnormalities indicated
by prolonged TpTe, TpTe/QTc, TpTe/QT, QTp, and QT
interval measurements. This novel finding may be one of
the reasons underlying arrhythmic events in patients with
myocarditis.
6. Study limitations
The main limitations of our study were the retrospective
design and small sample size. Utilization of cardiac MR
imaging in all patients could have provided more detailed
information about involved myocardial areas consistent
with myocarditis.
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